Results 11 to 20 of about 5,398,607 (364)
Preprocessing for Automating Early Detection of Cervical Cancer [PDF]
, 2011 Uterine Cervical Cancer is one of the most common forms of cancer in women worldwide. Most cases of cervical cancer can be prevented through screening programs aimed at detecting precancerous lesions. During Digital Colposcopy, colposcopic images or cervigrams are acquired in raw form.
Bhattacharyya, Debasis +2 more
arxiv +3 more sources
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
International Journal of Gynecological Cancer, 2023 In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP) published evidence-based guidelines for the management of patients with ...
D. Cibula +26 more
semanticscholar +1 more source
Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic
eLife, 2023 Background: At the onset of the COVID-19 pandemic cervical screening in the capital region of Sweden was canceled for several months. A series of measures to preserve and improve the cervical screening under the circumstances were instituted, including a
Miriam Elfström +2 more
doaj +1 more source
NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
The Journal of the National Comprehensive Cancer Network, 2023 The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment.
N. Abu-Rustum +37 more
semanticscholar +1 more source
Recent trends and analysis of Generative Adversarial Networks in Cervical Cancer Imaging [PDF]
Neuro Quantology, September 2022, Volume 20, Issue 9, Page
3302-3308, 2022 Cervical cancer is one of the most common types of cancer found in females. It contributes to 6-29% of all cancers in women. It is caused by the Human Papilloma Virus (HPV). The 5-year survival chances of cervical cancer range from 17%-92% depending upon the stage at which it is detected.
arxiv +1 more source
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
New England Journal of Medicine, 2021 BACKGROUND Pembrolizumab has efficacy in programmed death ligand 1 (PD-L1)-positive metastatic or unresectable cervical cancer that has progressed during chemotherapy.
N. Colombo +18 more
semanticscholar +1 more source
HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK
Pathogens, 2023 Cervical cancer is the fourth most common malignancy in females worldwide, and a leading cause of death in the United Kingdom (UK). The human papillomavirus (HPV) is the strongest risk factor for developing cervical intraepithelial neoplasia and cancer ...
Sunyoung Choi +3 more
semanticscholar +1 more source
Survival with Cemiplimab in Recurrent Cervical Cancer.
New England Journal of Medicine, 2022 BACKGROUND Patients with recurrent cervical cancer have a poor prognosis. Cemiplimab, the fully human programmed cell death 1 (PD-1)-blocking antibody approved to treat lung and skin cancers, has been shown to have preliminary clinical activity in this ...
K. Tewari +34 more
semanticscholar +1 more source
Ca, 2023 Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer ...
R. Siegel +3 more
semanticscholar +1 more source
Ca, 2021 This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer.
H. Sung +6 more
semanticscholar +1 more source